Anti-alpha-2-macroglobulin-like-1 autoantibodies are detected frequently and may be pathogenic in paraneoplastic pemphigus

Journal of Investigative Dermatology

Volumn 133, Issue 7, 2013, Pages 1785-1793

  Numata, Sanae ^a   Teye, Kwesi ^a   Tsuruta, Daisuke ^a,d   Sogame, Ryosuke ^a   Ishii, Norito ^a   Koga, Hiroshi ^a   Natsuaki, Yohei ^a   Tsuchisaka, Atsunari ^a   Hamada, Takahiro ^a   Karashima, Tadashi ^a   Nakama, Takekuni ^a   Furumura, Minao ^a   Ohata, Chika ^a   Kawakami, Tamihiro ^b   Schepens, Isabelle ^c   Borradori, Luca ^c   Hashimoto, Takashi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF BERN   (Switzerland)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN LIKE 1 ANTIBODY; AUTOANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL CULTURE; CHILD; CONTROLLED STUDY; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; KERATINOCYTE; MAJOR CLINICAL STUDY; NONHUMAN; PARANEOPLASTIC PEMPHIGUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHOOL CHILD;

EID: 84879410579     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.65     Document Type: Article

References (34)

1. Amagai M, Nishikawa T, Nousari HC et al. (1998) Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 102:775-82 (Pubitemid 28399610)
2. Anhalt GJ, Kim SC, Stanley JR et al. (1990) Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323:1729-35
3. Borradori L, Lombardi T, Samson J et al. (2001) Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+ ) follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol 137:269-72 (Pubitemid 32240777)
4. Fujimoto W, Kanehiro A, Kuwamoto-Hara K et al. (2002) Paraneoplastic pemphigus associated with Castleman's disease and asymptomatic bronchiolitis obliterans. Eur J Dermatol 12:355-9 (Pubitemid 34713102)
5. Galliano MF, Toulza E, Gallinaro H et al. (2006) A novel protease inhibitor of the macroglobulin family expressed in the human epidermis. J Biol Chem 281:5780-9 (Pubitemid 43847677)
6. Hashimoto K, Shafran KM, Webber PS et al. (1983) Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. J Exp Med 157:259-72 (Pubitemid 13176188)
7. Hashimoto T, Amagai M, Watanabe K et al. (1995) Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 104:829-34
8. Hashimoto T, Ogawa MM, Konohana A et al. (1990) Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. J Invest Dermatol 94:327-31 (Pubitemid 20061641)
9. Heizmann M, Itin P, Wernli M et al. (2001) Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Hematol 66:142-4 (Pubitemid 32096630)
10. Hsiao CJ, Hsu MM, Lee JY et al. (2001) Paraneoplastic pemphigus in association with a retroperitoneal Castleman's disease presenting with a lichen planus pemphigoides-like eruption. A case report and review of literature. Br J Dermatol 144:372-6 (Pubitemid 32178823)
11. Inaoki M, Kodera M, Fujimoto A et al. (2001) Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies. Br J Dermatol 144:610-3 (Pubitemid 32232023)
12. Ishii K, Harada R, Matsuo I et al. (2005) In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibo-dies in pemphigus vulgaris. J Invest Dermatol 124:939-46 (Pubitemid 40629094)
13. Izaki S, Yoshizawa Y, Hashimoto T et al. (1996) Paraneoplastic pemphigus: report of a case. J Dermatol 23:397-404 (Pubitemid 26234864)
14. Kim SC, Kwon YD, Lee IJ et al. (1997) cDNA cloning of the 210-kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex. J Invest Dermatol 109:365-9 (Pubitemid 27394653)
15. Kimyai-Asadi A, Jih MH (2001) Paraneoplastic pemphigus. Int J Dermatol 40:367-72 (Pubitemid 32878615)
16. Kiyokawa C, Ruhrberg C, Nie Z et al. (1998) Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex. J Invest Dermatol 111:1236-8 (Pubitemid 29115209)
17. Lee JSS, Pei Lin Ng P, Tao M et al. (2006) Paraneoplastic pemphigus resembling linear IgA bullous dermatosis. Int J Dermatol 45:1093-5 (Pubitemid 44317130)
18. Mahler V, Antoni C, Anhalt GJ et al. (1998) Graft-versus-host-like mucocuta-neous eruptions with serological features of paraneoplastic pemphigus and systemic lupus erythematosus in a patient with non-Hodgkin's lymphoma. Dermatology 197:78-83 (Pubitemid 28327847)
19. Mahoney MG, Wang ZH, Stanley JR (1999) Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J Invest Dermatol 113:22-5 (Pubitemid 29328153)
20. Martinez De Pablo MI, Iranzo P, Mascaro JM et al. (2005) Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone. Acta Derm Venereol 85:233-5 (Pubitemid 40695166)
21. Marzano AV, Vezzoli P, Mariotti F et al. (2005) Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma and Castleman disease. Br J Dermatol 153:214-5 (Pubitemid 41044558)
22. Mimouni D, Anhalt GJ, Lazarova Z et al. (2002) Paraneoplastic pemphigus in children and adolescents. Br J Dermatol 147:725-32 (Pubitemid 35286158)
23. Morioka S, Naito K, Ogawa H (1981) The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis. J Invest Dermatol 76:337-41 (Pubitemid 12236503)
24. Niimi Y, Ohyama B, Di Zenzo G et al. (2010) Paraneoplastic pemphigus presenting as mild cutaneous features of pemphigus foliaceus and lichenoid stomatitis with antidesmoglein 1 antibodies. Dermatol Res Pract 2010, pii931340
25. Nishibori Y, Hashimoto T, Ishiko A et al. (1995) Paraneoplastic pemphigus: the first case report from Japan. Dermatology 191:39-42
26. Oursler JR, Labib RS, Ariss-Abdo L et al. (1992) Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest 89: 1775-82
27. Reich K, Brinck U, Letschert M et al. (1999) Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus. Br J Dermatol 141:739-46 (Pubitemid 29512835)
28. Ruhrberg C, Hajibagheri MA, Simon M et al. (1996) Envoplakin, a novel precursor of the cornified envelope that has homology to desmoplakin. J Cell Biol 134:715-29 (Pubitemid 26271334)
29. Saleh MA, Ishii K, Yamagami J et al. (2012) Pathogenic anti-desmoglein 3 mAbs cloned from a paraneoplastic pemphigus patient by phage display. J Invest Dermatol 132:1141-8
30. Santi CG, Flores RS, Medina MM et al. (2005) Paraneoplastic pemphigus associated with pelvic inflammatory fibrosarcoma: a case report. J Dermatol 32:1014-20 (Pubitemid 43258830)
31. Schepens I, Jaunin F, Begre N et al. (2010) The protease inhibitor alpha-2-macroglobuline-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human. PLoS ONE 5:e12250
32. Seishima M, Satoh S, Nojiri M et al. (1997) Pemphigus IgG induces expression of urokinase plasminogen activator receptor on the cell surface of cultured keratinocytes. J Invest Dermatol 109:650-5 (Pubitemid 27465920)
33. Williams JV, Marks JG Jr, Billingsley EM (2000) Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus. Br J Dermatol 142:506-8 (Pubitemid 30159076)
34. Wolff H, Kunte C, Messer G et al. (1999) Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour. Br J Dermatol 140:313-6 (Pubitemid 29111363)